2015-2019 Europe Hemostasis Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - France, Germany, Italy, Spain, UK
![](/report_cover/2215/2015-2019-europe-hemostasis-diagnostics-market-france-germany-italy-spain-uk_en.gif)
Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800.
Summary
This comprehensive five-country report contains 500 pages, 120 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the European coagulation testing market during the next five years. The report explores business and technological trends in France, Germany, Italy, Spain, and the UK; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years. Coagulation TestsActivated Clotting Time (ACT) (1), Activated Protein C Resistance,Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX,Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others. Geographic CoverageFrance, Germany, Italy, Spain, UKSales and Market Share Analysis- Sales and market shares of major instrument and reagent suppliers. Competitive Assessments- Extensive strategic profiles ofmajor suppliers and emerging market entrants.
Market Segmentation Analysis
Comprehensive marketsegmentation analysis, including: - Hospitals - Commercial/Private Laboratories - Physician Offices - Ambulatory Care Centers- Test volume forecasts for over 40 major procedures,by country and market segment. Current and Emerging Products- Review of established and emerging procedures. - Comparison of automated and semi-automatedanalyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers. Technology Review- Analysis of current and emerging technologies and their potential market applications. - Comprehensive lists of companies developingor marketing new technologies and products by test. Strategic Recommendations- Product development and business expansion opportunities with significant market appeal. - Ideal product models with tentativeprices and operating characteristics. - Alternative market penetrationstrategies for instrument and reagent suppliers. - Potential market entry barriers and risksContains 500 pages and 120 tables
Summary
This comprehensive five-country report contains 500 pages, 120 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the European coagulation testing market during the next five years. The report explores business and technological trends in France, Germany, Italy, Spain, and the UK; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years. Coagulation TestsActivated Clotting Time (ACT) (1), Activated Protein C Resistance,Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX,Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others. Geographic CoverageFrance, Germany, Italy, Spain, UKSales and Market Share Analysis- Sales and market shares of major instrument and reagent suppliers. Competitive Assessments- Extensive strategic profiles ofmajor suppliers and emerging market entrants.
Market Segmentation Analysis
Comprehensive marketsegmentation analysis, including: - Hospitals - Commercial/Private Laboratories - Physician Offices - Ambulatory Care Centers- Test volume forecasts for over 40 major procedures,by country and market segment. Current and Emerging Products- Review of established and emerging procedures. - Comparison of automated and semi-automatedanalyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers. Technology Review- Analysis of current and emerging technologies and their potential market applications. - Comprehensive lists of companies developingor marketing new technologies and products by test. Strategic Recommendations- Product development and business expansion opportunities with significant market appeal. - Ideal product models with tentativeprices and operating characteristics. - Alternative market penetrationstrategies for instrument and reagent suppliers. - Potential market entry barriers and risksContains 500 pages and 120 tables
I. Introduction
II. Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Chlamydia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Human Herpes Virus -6 (HHV -6)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Papillomavirus (HPV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Syphilis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho - Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
VII. Spain: Market Size, Growth and Major Suppliers’ Sales and Market Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
BioRad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
GenProbe
Hologic
ID Biomedical
Innogenetics/Solvay
Kreatech
Life Technology
Lonza
Nanogen/Elitech
Novartis Diagnostics
OrthoClinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
WakoSpain Sexually - Transmitted Diseases Market Outlook and Opportunities
II. Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Chlamydia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Human Herpes Virus -6 (HHV -6)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Papillomavirus (HPV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Syphilis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho - Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
VII. Spain: Market Size, Growth and Major Suppliers’ Sales and Market Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
BioRad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
GenProbe
Hologic
ID Biomedical
Innogenetics/Solvay
Kreatech
Life Technology
Lonza
Nanogen/Elitech
Novartis Diagnostics
OrthoClinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
WakoSpain Sexually - Transmitted Diseases Market Outlook and Opportunities
LIST OF TABLES
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Pap Smear/HPV Tests
Major Companies Developing or Marketing Syphilis Tests
Spain Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Chlamydia Diagnostics Sales by Major Supplier
Spain Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Herpes Testing Market Diagnostics Sales by Major Supplier
Spain PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Syphilis Testing Market Diagnostics Sales by Major Supplier
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Pap Smear/HPV Tests
Major Companies Developing or Marketing Syphilis Tests
Spain Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Chlamydia Diagnostics Sales by Major Supplier
Spain Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Herpes Testing Market Diagnostics Sales by Major Supplier
Spain PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Syphilis Testing Market Diagnostics Sales by Major Supplier